BLISSGVS: Revenue and net profit increased, with new leadership and regulatory fine payment noted

About this update from Bliss Gvs Pharma Limited

Revenue and net profit grew year-over-year for the quarter ended September 30, 2024. A new Chairman was appointed, and a regulatory fine was paid for director appointment non-compliance, with the company considering an appeal.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Bliss Gvs Pharma Limited